Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
MAIA Biotechnology, Inc. (MAIA) had Stock-Based Compensation of $1.91M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-23.25M |
|
-- |
|
-- |
|
$16.96M |
|
$-16.96M |
|
$-6.30M |
|
$-23.25M |
|
$-23.25M |
|
$-23.25M |
|
$-23.25M |
|
$-23.25M |
|
$-23.25M |
|
$-16.96M |
|
$-16.96M |
|
22.20M |
|
22.20M |
|
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$10.15M |
|
-- |
|
$0.00M |
|
$10.16M |
|
$3.83M |
|
-- |
|
$2.69M |
|
$6.52M |
|
$3.63M |
|
$3.63M |
|
$3.63M |
|
26.16M |
|
| Cash Flow Statement Financials | |
$-15.70M |
|
-- |
|
$18.18M |
|
$7.15M |
|
$9.60M |
|
$2.45M |
|
|
Stock-Based Compensation |
$1.91M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-639.81% |
|
-639.81% |
|
-228.99% |
|
-639.81% |
|
$0.14 |
|
$-0.71 |
|
$-0.71 |
|